Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €77.07 EUR
Change Today -0.39 / -0.50%
Volume 96.9K
As of 4:21 AM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rolf A. Classon

Member of The Supervisory Board and Vice Chairman of Regulatory & Reimbursement Assessment Committee, Fresenius Medical Care AG & Co. KGAA
AgeTotal Calculated CompensationThis person is connected to 49 board members in 9 different organizations across 18 different industries.

See Board Relationships


Mr. Rolf A. Classon served as a Member of the Portfolio Services Group and Operating Partner of Growth Buyout Fund at Health Evolution Partners. He served as the Chief Executive Officer and President of Bayer Healthcare, LLC at Bayer AG. Mr. Classon served as the Interim Chief Executive Officer and President of Hill-Rom Holdings, Inc. from May 11, 2005 to March 20, 2006. He was the interim President and Chief Executive Officer of Hillenbrand Industries. He served as ...

Read Full Background

Corporate Headquarters*

Else-Kröner Strasse 1
Bad Homburg, Hessen 61352


Phone: 49 6172 6090
Fax: 49 6172 609 2301

Board Members Memberships*

Former Chairman and Chairman of Nominating & Corporate Governance Committee
Chairman of the Board
Chairman of the Board
Non-Executive Chairperson
Former Director, Chairman of Compensation Committee, Member of Finance & Audit Committee and Member of Executive Committee
Chairman of the Board, Chairman of Mergers & Acquisitions Committee, Vice Chairman of Nominating/Corporate Governance Committee and Member of Compensation & Management Development Committee
Former Independent Director and Chairman of Nominating & Corporate Governance Committee
Former Chairman
Former Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Former Outside Director, Member of Governance & Public Policy Committee and Member of Technology Committee
Former Independent Director, Member of Nominating & Corporate Governance Committee and Member of Strategic Alternatives Committee
Independent Non Executive Director, Member of Audit Committee and Member of Compensation Committee
Chairman and Chairman of Nomination & Governance Committee
Chairman and Member of Nominating Committee
Former Chairman of the Board
Former Director and Member of Audit Committee
Director and Member of Audit Committee


Unknown/Other Education
Göteborgs universitet
Master's Degree
Göteborgs universitet
Göteborgs universitet
Unknown/Other Education
Technical University in Gothenburg Sweden

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FME:GR €77.01 EUR -0.45


Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
Olivier Brandicourt Chief Executive Officer and Director
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FRESENIUS MEDICAL CARE AG &, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at